As of September 2024, Realcan Pharmaceutical Group has a market cap of $500.84M. This makes Realcan Pharmaceutical Group the world's 11452th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $496.61M | -28.13% |
2023 | $691.03M | -20.63% |
2022 | $870.65M | 4.83% |
2021 | $830.50M | -24.86% |
2020 | $1.11B | -31.99% |
2019 | $1.63B | 10.33% |
2018 | $1.47B | -48.18% |
2017 | $2.84B | -4.67% |
2016 | $2.98B | -9.64% |
2015 | $3.30B | 122.15% |
2014 | $1.49B | 27.58% |
2013 | $1.16B | 53.58% |
2012 | $758.01M | - |